Abstract
Positron emission tomography (PET) using F-18 fluorodeoxyglucose (FDG) is a very effective imaging modality in the diagnosis, staging, and monitoring of a variety of malignant conditions. The principle of imaging is based on the enhanced utilization of glucose by cancer. In this report, we describe a patient with renal cell carcinoma who showed FDG uptake isometabolic to normal liver.
MeSH terms
-
Carcinoma, Renal Cell / diagnostic imaging*
-
Carcinoma, Renal Cell / metabolism
-
False Negative Reactions
-
Female
-
Fluorodeoxyglucose F18*
-
Humans
-
Kidney Neoplasms / diagnostic imaging*
-
Kidney Neoplasms / metabolism
-
Liver / diagnostic imaging*
-
Liver / metabolism
-
Middle Aged
-
Radiopharmaceuticals*
-
Tomography, Emission-Computed*
Substances
-
Radiopharmaceuticals
-
Fluorodeoxyglucose F18